Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
-
H&R Block Reports Fiscal 2026 Results and Enters Fiscal 2027 with Confidence
-
CNB Financial Corporation Announces Quarterly Dividend for Common Stock
-
Codexis Reports Second Quarter 2026 Financial Results
-
BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress
-
Inuvo Announces Planned Financial Leadership Transitions
-
Canterbury Park Holding Corporation Reports Second Quarter Results
-
High Roller Technologies Advances Planned U.S. Prediction Markets Launch; Reports Second Quarter 2026 Results
-
Inuvo Reports Second Quarter 2026 Results
-
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 31, 2026
-
Anterix Inc. Reports First Quarter Fiscal Year 2027 Results
-
Mobia Medical Reports Second Quarter 2026 Financial Results
-
Factorial Announces Second Quarter 2026 Results
-
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
-
Spectral AI Announces 2026 Second Quarter Financial Results
-
Comscore Announces ROI Strategy to Transform the Business
-
LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
-
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
-
GrowGeneration Reports Second Quarter 2026 Financial Results
-
Snail, Inc. Reports Second Quarter 2026 Financial Results
-
Black Rock Coffee Bar, Inc. Reports Second Quarter 2026 Results
-
Inuvo Announces Planned Financial Leadership Transitions
-
Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
-
Digital Realty Declares Quarterly Cash Dividends for Common and Preferred Stock
-
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
-
Firefly Aerospace Announces Extension of Multi-Launch Agreement with Lockheed Martin Through 2031
-
Mobile Infrastructure Reports Second Quarter 2026 Financial Results
-
Hour Loop Reports Second Quarter of 2026 Results
-
Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results
-
IZEA Reports Q2 2026 Revenue of $5.8 million, Advances Enterprise-Focused Growth Strategy
-
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
-
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates
-
Erasca Reports Second Quarter 2026 Business Updates and Financial Results
-
Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
-
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
-
Leonardo DRS Demonstrates Defeat of Group 1-2 Unmanned Aerial System Threats for Fielded SGT STOUT M-SHORAD
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1
-
Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity
-
Wrap Reports Q2 Revenue of $2.1 Million, Up 103% Year Over Year; ATF Classifies BolaWrap 150 as Non-Firearm, Non-Weapon
-
Xcel Brands to Host Second Quarter 2026 Earnings Call on August 14, 2026
-
Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Greystone Capital Advisors Arranges $103 Million Bridge Loan for 864 Unit Texas Multifamily Portfolio
-
ASHA Names 2026 Media Champion Award Recipients
-
Rampart Withdraws Appeal of USPTO’s Invalidation Decision
-
First Female NASA Space Shuttle Pilot Named High Point University’s Undergraduate Commencement Speaker for 2027
-
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
-
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
-
New Drug to Treat Pancreatic Cancer May Be a “Game Changer” as 10 Intermountain Hospitals Join National Initiative

